Placenta
Volume 29, Issue 11 , Pages 932-936 , November 2008

Dynamic Regulation of alpha-Dystroglycan in Mouse Placenta

  • M. Santhanakrishnan
    • ,
  • K. Ray
    • ,
  • K. Oppenheimer
    • ,
  • E.A. Bonney

      Affiliations

    • Corresponding Author InformationCorresponding author. Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Vermont College of Medicine, Given Building, Room C-244, 89 Beaumont Avenue, Burlington, VT 05405, USA. Tel.: +1 802 656 8677; fax: +1 802 656 8771.

,Accepted 26 August 2008.

References 

  1. Nahmias AJ, Kourtis AP. The great balancing acts. The pregnant woman, placenta, fetus, and infectious agents. Clin Perinatol. 1997;24(2):497–521
  2. Griffith BP, McCormick SR, Fong CK, Lavallee JT, Lucia HL, Goff E. The placenta as a site of cytomegalovirus infection in guinea pigs. J Virol. 1985;55(2):402–409
  3. Constantin CM, Masopust D, Gourley T, Grayson J, Strickland OL, Ahmed R, et al. Normal establishment of virus-specific memory CD8 T cell pool following primary infection during pregnancy. J Immunol. 2007;179(7):4383–4389
  4. Mims CA. Immunofluorescence study of the carrier state and mechanism of vertical transmission in lymphocytic choriomeningitis virus infection in mice. J Pathol Bacteriol. 1966;91(2):395–402
  5. Nachtigal MW, Bock ME, Kowaluk BA, Cattini PA. Chorionic gonadotrophin and c-myc expression in growing and growth-inhibited (intermediate) trophoblasts. Placenta. 1992;13(4):371–383
  6. Cao W, Henry MD, Borrow P, Yamada H, Elder JH, Ravkov EV, et al. Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science. 1998;282(5396):2079–2081
  7. Spiropoulou CF, Kunz S, Rollin PE, Campbell KP, Oldstone MB. New World arenavirus clade C, but not clade A and B viruses, utilizes alpha-dystroglycan as its major receptor. J Virol. 2002;76(10):5140–5146
  8. Mims CA. Pathogenesis of viral infections of the fetus. Prog Med Virol. 1968;10:194–237
  9. Mims CA. Effect on the fetus of maternal infection with Lymphocytic Choriomeningitis (LCM) Virus. J Infect Dis. 1969;120(5):582–597
  10. Barton LL, Peters CJ, Ksiazek TG. Lymphocytic choriomeningitis virus: an unrecognized teratogenic pathogen. Emerg Infect Dis. 1995;1(4):152–153
  11. Barton LL, Mets MB. Congenital lymphocytic chroiomeningitis virus infection: decade of rediscovery. Clin Infect Dis. 2001;33(3):370–374
  12. Deyst KA, Bowe MA, Leszyk JD, Fallon JR. The alpha-dystroglycan-beta-dystroglycan complex. Membrane organization and relationship to an agrin receptor. J Biol Chem. 1995;270(43):25956–25959
  13. Smalheiser NR, Kim E. Purification of cranin, a laminin binding membrane protein. Identity with dystroglycan and reassessment of its carbohydrate moieties. J Biol Chem. 1995;270(25):15425–15433
  14. Ervasti JM, Campbell KP. Dystrophin and the membrane skeleton. Curr Opin Cell Biol. 1993;5(1):82–87
  15. Martin PT. Dystroglycan glycosylation and its role in matrix binding in skeletal muscle. Glycobiology. 2003;13(8):55R–66R
  16. Imperiali M, Thoma C, Pavoni E, Brancaccio A, Callewaert N, Oxenius A. O Mannosylation of alpha-dystroglycan is essential for lymphocytic choriomeningitis virus receptor function. J Virol. 2005;79(22):14297–14308
  17. Michele DE, Barresi R, Kanagawa M, Saito F, Cohn RD, Satz JS, et al. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature. 2002;418(6896):417–422
  18. Asada M, Furukawa K, Segawa K, Endo T, Kobata A. Increased expression of highly branched N-glycans at cell surface is correlated with the malignant phenotypes of mouse tumor cells. Cancer Res. 1997;57(6):1073–1080
  19. Ervasti JM, Burwell AL, Geissler AL. Tissue-specific heterogeneity in alpha-dystroglycan sialoglycosylation. Skeletal muscle alpha-dystroglycan is a latent receptor for Vicia villosa agglutinin b4 masked by sialic acid modification. J Biol Chem. 1997;272(35):22315–22321
  20. Willer T, Prados B, Falcon-Perez JM, Renner-Muller I, Przemeck GK, Lommel M, et al. Targeted disruption of the Walker–Warburg syndrome gene Pomt1 in mouse results in embryonic lethality. Proc Natl Acad Sci U S A. 2004;101(39):14126–14131
  21. Grewal PK, McLaughlan JM, Moore CJ, Browning CA, Hewitt JE. Characterization of the LARGE family of putative glycosyltransferases associated with dystroglycanopathies. Glycobiology. 2005;15(10):912–923
  22. Sevilla N, Kunz S, McGavern DB, Oldstone MB. Infection of dendritic cells by lymphocytic choriomeningitis virus. Curr Top Microbiol Immunol. 2003;276:125–144
  23. Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, Campbell KP. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature. 1992;355(6362):696–702
  24. Rojek JM, Spiropoulou CF, Campbell KP, Kunz S. Old World C clade New World arenaviruses mimic the molecular mechanism of receptor recognition used by alpha-dystroglycan's host-derived ligands. J Virol. 2007;81(11):5685–5695
  25. Hayashi YK, Ogawa M, Tagawa K, Noguchi S, Ishihara T, Nonaka I, et al. Selective deficiency of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy. Neurology. 2001;57(1):115–121
  26. Williamson RA, Henry MD, Daniels KJ, Hrstka RF, Lee JC, Sunada Y, et al. Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null mice. Hum Mol Genet. 1997;6(6):831–841
  27. Yotsumoto S, Fujiwara H, Horton JH, Mosby TA, Wang X, Cui Y, et al. Cloning and expression analyses of mouse dystroglycan gene: specific expression in maternal decidua at the peri-implantation stage. Hum Mol Genet. 1996;5(9):1259–1267
  28. Bustamante JJ, Dai G, Soares MJ. Pregnancy and lactation modulate maternal splenic growth and development of the erythroid lineage in the rat and mouse. Reprod Fertil Dev. 2008;20(2):303–310

PII: S0143-4004(08)00292-0

doi: 10.1016/j.placenta.2008.08.021

Placenta
Volume 29, Issue 11 , Pages 932-936 , November 2008

Article Tools

* Image Usage & Resolution